{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:35:59Z","timestamp":1790642159835,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81300125"],"award-info":[{"award-number":["81300125"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009047","name":"Shantou University","doi-asserted-by":"publisher","award":["201402"],"award-info":[{"award-number":["201402"]}],"id":[{"id":"10.13039\/100009047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ijcard.2017.03.065","type":"journal-article","created":{"date-parts":[[2017,7,22]],"date-time":"2017-07-22T19:48:06Z","timestamp":1500752886000},"page":"367-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Elevated circulating IL-32 presents a poor prognostic outcome in patients with heart failure after myocardial infarction"],"prefix":"10.1016","volume":"243","author":[{"given":"Wanling","family":"Xuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0201-1737","authenticated-orcid":false,"given":"Ruijie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yequn","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6298-8806","authenticated-orcid":false,"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuerui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2017.03.065_bb0005","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ejhf.497","article-title":"Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation","volume":"18","author":"Ter Maaten","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0010","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.2174\/0929867322666150415152532","article-title":"Inflammatory biomarkers and therapeutic targets in heart failure","volume":"22","author":"Papadimitriou","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10741-016-9533-z","article-title":"The role of inflammation and cell death in the pathogenesis, progression and treatment of heart failure","volume":"21","author":"Briasoulis","year":"2016","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0020","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.18632\/oncotarget.7007","article-title":"Il-32theta inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the stat3 pathway in colon cancer","volume":"7","author":"Bak","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijcard.2017.03.065_bb0025","first-page":"1","article-title":"Role of interleukin-32 in the mechanism of chronic inflammation in igg4-related disease and as a predictive biomarker for drug-free remission","author":"Shimizu","year":"2015","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0030","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s12032-013-0472-4","article-title":"Il-32 expression is an independent prognostic marker for gastric cancer","volume":"30","author":"Ishigami","year":"2013","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0035","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00296-012-2385-5","article-title":"Il-32 aggravates synovial inflammation and bone destruction and increases synovial natural killer cells in experimental arthritis models","volume":"33","author":"Park","year":"2013","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0040","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2567.2010.03377.x","article-title":"Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene","volume":"132","author":"Lee","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.ijcard.2017.03.065_bb0045","doi-asserted-by":"crossref","first-page":"8413768","DOI":"10.1155\/2016\/8413768","article-title":"Il-32: a novel pluripotent inflammatory interleukin, towards gastric inflammation, gastric cancer, and chronic rhino sinusitis","volume":"2016","author":"Khawar","year":"2016","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0050","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/01902148.2015.1033569","article-title":"Synthetic double-stranded RNA induces interleukin-32 in bronchial epithelial cells","volume":"41","author":"Ota","year":"2015","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0055","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1073\/pnas.0813334106","article-title":"Il-32-dependent effects of IL-1beta on endothelial cell functions","volume":"106","author":"Nold-Petry","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0060","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/imm.12374","article-title":"C-jun n-terminal kinase and akt signalling pathways regulating tumour necrosis factor-alpha-induced interleukin-32 expression in human lung fibroblasts: implications in airway inflammation","volume":"144","author":"Li","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.ijcard.2017.03.065_bb0065","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/hep.24285","article-title":"Interleukin-32: a new proinflammatory cytokine involved in hepatitis c virus-related liver inflammation and fibrosis","volume":"53","author":"Moschen","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ijcard.2017.03.065_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2014.05.002","article-title":"Il-32gamma overexpression accelerates streptozotocin (stz)-induced type 1 diabetes","volume":"69","author":"Jhun","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.ijcard.2017.03.065_bb0075","doi-asserted-by":"crossref","first-page":"e9458","DOI":"10.1371\/journal.pone.0009458","article-title":"Interleukin-32beta propagates vascular inflammation and exacerbates sepsis in a mouse model","volume":"5","author":"Kobayashi","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2017.03.065_bb0080","doi-asserted-by":"crossref","first-page":"38566","DOI":"10.18632\/oncotarget.6160","article-title":"Decreased severity of collagen antibody and lipopolysaccharide-induced arthritis in human IL-32beta overexpressed transgenic mice","volume":"6","author":"Park","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijcard.2017.03.065_bb0085","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1165\/rcmb.2013-0234OC","article-title":"Interleukin-32gamma suppresses allergic airway inflammation in mouse models of asthma","volume":"50","author":"Bang","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0090","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10741-013-9396-5","article-title":"Clinical use of novel biomarkers in heart failure: towards personalized medicine","volume":"19","author":"Schmitter","year":"2014","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0095","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(03)13976-1","article-title":"B-type natriuretic peptide in cardiovascular disease","volume":"362","author":"de Lemos","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2017.03.065_bb0100","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clinbiochem.2014.11.002","article-title":"Evidence based application of BNP\/NT-proBNP testing in heart failure","volume":"48","author":"Don-Wauchope","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0105","first-page":"337","article-title":"Initial infarct size predicts subsequent cardiac remodeling in the rat infarct model: an in vivo serial pinhole gated SPECT study","volume":"47","author":"Maskali","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0110","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0735-1097(94)00431-O","article-title":"Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction","volume":"25","author":"Chareonthaitawee","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0115","doi-asserted-by":"crossref","first-page":"7853","DOI":"10.1074\/jbc.M808824200","article-title":"Neutralization of interleukin-18 ameliorates ischemia\/reperfusion-induced myocardial injury","volume":"284","author":"Venkatachalam","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0120","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0735-1097(02)01738-2","article-title":"Improved myocardial ischemia\/reperfusion injury in mice lacking tumor necrosis factor-alpha","volume":"39","author":"Maekawa","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0125","first-page":"828","article-title":"The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction","volume":"38","author":"van Hout","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0130","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCRESAHA.114.302533","article-title":"Myocardial extracellular matrix: an ever-changing and diverse entity","volume":"114","author":"Rienks","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0135","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1161\/CIRCRESAHA.116.305628","article-title":"Trem-1 mediates inflammatory injury and cardiac remodeling following myocardial infarction","volume":"116","author":"Boufenzer","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0140","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.intimp.2016.06.002","article-title":"TIMP-1 expression induced by IL-32 is mediated through activation of AP-1 signal pathway","volume":"38","author":"Xu","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0145","first-page":"H76","article-title":"IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice","volume":"297","author":"Yu","year":"2009","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0150","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4014\/jmb.1404.04012","article-title":"Interleukin-32gamma transgenic mice resist LPS-mediated septic shock","volume":"24","author":"Kim","year":"2014","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0155","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/ar3850","article-title":"Enhanced susceptibility to lipopolysaccharide-induced arthritis and endotoxin shock in interleukin-32 alpha transgenic mice through induction of tumor necrosis factor alpha","volume":"14","author":"Nakayama","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0160","doi-asserted-by":"crossref","first-page":"21082","DOI":"10.1073\/pnas.1015418107","article-title":"Paradoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitis","volume":"107","author":"Choi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0165","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cyto.2010.09.002","article-title":"Native IL-32 is released from intestinal epithelial cells via a non-classical secretory pathway as a membrane-associated protein","volume":"53","author":"Hasegawa","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.ijcard.2017.03.065_bb0170","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1074\/jbc.M111.288290","article-title":"Interleukin 32 (IL-32) contains a typical alpha-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1","volume":"287","author":"Heinhuis","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcard.2017.03.065_bb0175","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1007\/s00018-013-1301-9","article-title":"Novel insights into the biology of interleukin-32","volume":"70","author":"Joosten","year":"2013","journal-title":"Cell. Mol. Life Sci."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316343807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316343807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T21:26:49Z","timestamp":1535578009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316343807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":35,"alternative-id":["S0167527316343807"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.03.065","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated circulating IL-32 presents a poor prognostic outcome in patients with heart failure after myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.03.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}